Raymond Debbane - Aug 1, 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Stock symbol
LXRX
Transactions as of
Aug 1, 2022
Transactions value $
$2,456,500
Form type
4
Date filed
8/1/2022, 04:13 PM
Previous filing
Jul 6, 2022
Next filing
Oct 5, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $2.46M +983K +22.74% $2.50 5.3M Aug 1, 2022 By Invus US Partners LLC
holding LXRX Common Stock 332K Aug 1, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.